EP0923602A4 - Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation - Google Patents

Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation

Info

Publication number
EP0923602A4
EP0923602A4 EP97932497A EP97932497A EP0923602A4 EP 0923602 A4 EP0923602 A4 EP 0923602A4 EP 97932497 A EP97932497 A EP 97932497A EP 97932497 A EP97932497 A EP 97932497A EP 0923602 A4 EP0923602 A4 EP 0923602A4
Authority
EP
European Patent Office
Prior art keywords
methods
compositions containing
containing sperm
sperm antigens
immunocontraceptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932497A
Other languages
German (de)
English (en)
Other versions
EP0923602A1 (fr
Inventor
Jeffrey D Bleil
Mich B Hein
Louis H Bookbinder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chesapeake Perl Inc
Original Assignee
ZYGAM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZYGAM Inc filed Critical ZYGAM Inc
Publication of EP0923602A1 publication Critical patent/EP0923602A1/fr
Publication of EP0923602A4 publication Critical patent/EP0923602A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP97932497A 1996-07-03 1997-07-03 Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation Withdrawn EP0923602A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67489596A 1996-07-03 1996-07-03
PCT/US1997/011719 WO1998000440A1 (fr) 1996-07-03 1997-07-03 Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation
US674895 2003-09-29

Publications (2)

Publication Number Publication Date
EP0923602A1 EP0923602A1 (fr) 1999-06-23
EP0923602A4 true EP0923602A4 (fr) 2005-06-15

Family

ID=24708328

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932497A Withdrawn EP0923602A4 (fr) 1996-07-03 1997-07-03 Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation

Country Status (5)

Country Link
EP (1) EP0923602A4 (fr)
JP (1) JP2000514430A (fr)
AU (1) AU3594397A (fr)
CA (1) CA2259147A1 (fr)
WO (1) WO1998000440A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004026240A2 (fr) * 2002-09-19 2004-04-01 Research Development Foundation Immunocontraceptifs animaux exprimes dans des plantes et utilisation correspondante
DE102007030835A1 (de) * 2007-07-03 2009-01-08 Josef Waida Mit Ball bespielbares Sportgerät in verschiedenen Stellungen
EP3194420B3 (fr) * 2014-09-17 2024-02-14 Cornell University Identification de l'état de la fertilité masculine par détermination de la capacitation du sperme

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006113A1 (fr) * 1994-08-22 1996-02-29 Akzo Nobel N.V. Nouveaux peptides immuno-contraceptifs
WO1996015807A1 (fr) * 1994-11-21 1996-05-30 Scofield Virginia L Utilisation du sperme comme vecteurs vaccinaux

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006113A1 (fr) * 1994-08-22 1996-02-29 Akzo Nobel N.V. Nouveaux peptides immuno-contraceptifs
WO1996015807A1 (fr) * 1994-11-21 1996-05-30 Scofield Virginia L Utilisation du sperme comme vecteurs vaccinaux

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9800440A1 *

Also Published As

Publication number Publication date
EP0923602A1 (fr) 1999-06-23
WO1998000440A1 (fr) 1998-01-08
CA2259147A1 (fr) 1998-01-08
JP2000514430A (ja) 2000-10-31
AU3594397A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
GB9613986D0 (en) Ink-like or cream-like exothermic composition, exothermic device made thereof and manufacturing method of exothermic device
HUP9901874A3 (en) Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof
AU4244596A (en) Fluorocarbon containing coatings, compositions and methods of use
HUP9901629A3 (en) Use of r(+)-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
EP0925175A4 (fr) Formulations contenant de la maleimide et utilisations de ces dernieres
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
ZA971964B (en) Azolobenzazepine derivatives and compositions and method of use thereof.
GB2327190B (en) Process for the preparation of depilatory compositions and their use
EP0756636A4 (fr) Chondroitinases i et ii, leurs procedes de preparation et leur utilisation
ZA961948B (en) 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof
GB9717598D0 (en) Novel composition and use
EP0934427A4 (fr) Compositions d'antigenes du groupe sanguin rh et procedes d'utilisation
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
EP0919576A4 (fr) Nouveau copolymere, son procede de preparation et son utilisation
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
IL128614A0 (en) Naphthyl compounds, intermediates, compositions, and methods of use
EP1374894A3 (fr) Oligonucléotides immunostimulants, compositions et utilisations correspondantes
EP0923602A4 (fr) Compositions immunocontraceptives contenant des antigenes de sperme et procedes d'utilisation
EP0852503A4 (fr) Composition pour le traitement de la diarrhee, son utilisation et sa preparation
AU3630695A (en) Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
IL113916A0 (en) Carbamoylcarbohydrazides their preparation compositions containing them and their use
GB9420616D0 (en) Method, compositions and use
HUP0100542A3 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990121

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20050428

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CHESAPEAKE PERL, INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1018069

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061020